Search results for "medwatch"
Bleeding risk of dabigatran under scrutiny
Serious bleeding events have been reported in patients taking dabigatran (Pradaxa), according to a new FDA MedWatch alert.
https://immattersacp.org/weekly/archives/2011/12/13/7.htm
13 Dec 2011
Warning on an antipsychotic; generic rosuvastatin approval
This update covers a warning that aripiprazole may be associated with compulsive or uncontrollable urges, as well as approval of the first generic version of rosuvastatin tablets.
https://immattersacp.org/archives/2016/07/fda.htm
1 Jul 2016
Jantoven and other meds recalled
HRSA needs grant reviewers
https://immattersacp.org/weekly/archives/2011/03/01/7.htm
1 Mar 2011
Children's medications recalled by McNeil
Put words in our mouth
https://immattersacp.org/weekly/archives/2010/05/11/8.htm
11 May 2010
PPIs get warning on fracture risk
The next issue of ACP Internist is online and coming to your mailbox
https://immattersacp.org/weekly/archives/2010/06/08/7.htm
8 Jun 2010
Liver injuries found in patients on orlistat
Suggest a colleague as a Top Hospitalist
https://immattersacp.org/weekly/archives/2010/06/08/8.htm
8 Jun 2010
CDC offers updated guidance on national meningitis outbreak due to contaminated methylprednisolone
The CDC is offering updated guidance on the current national meningitis outbreak.
https://immattersacp.org/weekly/archives/2012/10/16/7.htm
16 Oct 2012
Proton-pump inhibitors to carry warning about C. diff
The FDA warned last week that proton-pump inhibitors (PPIs) may be associated with an increased risk of Clostridium difficile–associated diarrhea (CDAD).
https://immattersacp.org/weekly/archives/2012/02/14/7.htm
14 Feb 2012
FDA reviewing safety of HIV drug combo
ACP seeks member feedback on new Clinical Information page for Web site ACP solicits member input on CDC survey College Master to be named president of International Society of Internal Medicine
https://immattersacp.org/weekly/archives/2010/03/02/8.htm
2 Mar 2010
Warning on an antipsychotic; generic rosuvastatin approval
This update covers new warnings on the entire class of opioids and approval of the first leadless pacemaker approved to treat heart rhythm disorders.
https://immattersacp.org/archives/2016/06/fda.htm
1 Jun 2016